Technical Analysis for TENX - Tenax Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 1.2 -1.64% -0.02
TENX closed up 0.83 percent on Thursday, January 17, 2019, on 28 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Flat
See historical TENX trend table...

Date Alert Name Type % Chg
Jan 17 20 DMA Support Bullish -1.64%
Jan 17 Narrow Range Bar Range Contraction -1.64%
Jan 16 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.83%
Jan 16 Narrow Range Bar Range Contraction -0.83%
Jan 16 Upper Bollinger Band Walk Strength -0.83%
Jan 16 Inside Day Range Contraction -0.83%
Jan 16 Upper Bollinger Band Touch Strength -0.83%
Jan 15 Shooting Star Candlestick Bearish -3.23%
Jan 15 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -3.23%
Jan 15 20 DMA Support Bullish -3.23%

Older signals for TENX ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Tenax Therapeutics, Inc., a specialty pharmaceutical company, focused on the development and commercialization of a portfolio of products for the critical care market in the United States and Canada. It focuses on the development and commercialization of pharmaceutical products containing levosimendan, 2.5 mg/ml concentrate for solution for infusion/5ml vial for use in the reduction of morbidity and mortality in cardiac surgery patients at risk for developing Low Cardiac Output Syndrome. The company also develops Oxycyte, a systemic perfluorocarbon product for use as oxygen carrier in the situations of acute ischemia; and a range of perfluorocarbon-based oxygen carriers for use in personal care, topical wound healing, and other topical indications. Its Oxycyte is under Phase II-b clinical trials for the treatment of traumatic brain injury. In addition, the company offers Dermacyte line of topical cosmetic products that promote the appearance of skin health and other cosmetic benefits; and Wundecyte, a wound-healing gel. It sells Dermacyte through distribution agreements, on-line retailers, and direct sales to physician and medical spa facilities. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is headquartered in Morrisville, North Carolina.
Is TENX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 12.63
52 Week Low 1.03
Average Volume 664,458
200-Day Moving Average 4.9821
50-Day Moving Average 2.1465
20-Day Moving Average 1.1765
10-Day Moving Average 1.195
Average True Range 0.2166
ADX 27.89
+DI 32.3978
-DI 15.785
Chandelier Exit (Long, 3 ATRs ) 0.8002
Chandelier Exit (Short, 3 ATRs ) 1.6798
Upper Bollinger Band 1.2795
Lower Bollinger Band 1.0735
Percent B (%b) 0.71
BandWidth 17.509562
MACD Line -0.226
MACD Signal Line -0.3169
MACD Histogram 0.0909
Fundamentals Value
Market Cap 34.45 Million
Num Shares 28.2 Million
EPS -1.43
Price-to-Earnings (P/E) Ratio -0.85
Price-to-Sales 0.00
Price-to-Book 1.15
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.36
Resistance 3 (R3) 1.36 1.31 1.34
Resistance 2 (R2) 1.31 1.28 1.31 1.33
Resistance 1 (R1) 1.27 1.25 1.29 1.27 1.32
Pivot Point 1.22 1.22 1.23 1.22 1.22
Support 1 (S1) 1.17 1.18 1.20 1.17 1.12
Support 2 (S2) 1.12 1.16 1.12 1.11
Support 3 (S3) 1.08 1.12 1.10
Support 4 (S4) 1.08